https://www.marketscreener.com/quote/stock/PROTAGONIST-THERAPEUTICS--30494509/news/Protagonist-Therapeutics-Inc-Announces-Two-New-Phase-3-ICONIC-Studies-in-Psoriasis-Evaluating-JNJ-45443886/?utm_source=telegram&utm_medium=social&utm_campaign=share